ALLENA PHARMACEUTICALS, INC.
CIK 0001624658
Revenue (TTM)
—
Q2 Aug 2022
Net Income (TTM)
−$46.91M
+18.4% YoY
Q2 Aug 2022
EPS Diluted (TTM)
—
Q2 Aug 2022
Gross Margin
—
Q2 Aug 2022
Operating Margin
—
Q2 Aug 2022
Net Margin
—
Q2 Aug 2022
Free Cash Flow (TTM)
−$49.03M
Q2 Aug 2022
Cash
$6.59M
Q2 Aug 2022
Total Debt
$12.06M
Q2 Aug 2022
Shares Outstanding
122.08M sh
Q2 Aug 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.